shutterstock-2400006799

Endometriosis: experimental saliva tests will be reimbursed

undefined undefined 12 février 2025 undefined 09h30

The Editor

This is the exciting news that could change the lives of millions of women suffering from endometriosis. On Monday, February 10th, Health Minister Catherine Vautrin announced the launch of a saliva test that can diagnose endometriosis. Currently in the experimental phase, this device will be covered by health insurance starting Tuesday, February 11th.


A test available for 25,000 women

« It will cost €800 per woman » which will be covered by the government, as stated by Catherine Vautrin. This "Endotest," designed by the Ziwig laboratory, detects endometriosis through saliva by analyzing and sequencing RNA. Thanks to promising studies, the High Authority of Health (HAS) has given the green light to roll out the program for larger scale experimentation

According to the Ministry of Health, around 25,000 women over the age of 18 will be able to benefit from full coverage of these tests in the coming months. « As soon as we have results concerning these patients, the High Health Authority will provide a definitive opinion that will highlight the validity of the test and, ultimately, offer coverage for all the women in our country », stated Catherine Vautrin on France 2. 


Two million women affected by endometriosis in France

Currently, endometriosis affects one in ten people, which means two million French women. On a global scale, 10% of women are victims of endometriosis. This condition is caused by the migration of cells from the endometrium.

endometrium (wall of the uterus) outside the uterus. These then "move" to settle on the ovaries, the vagina, and sometimes even at the level of the digestive and urinary organs. This creates strong pelvic pain, especially during menstruation and sexual intercourse. Endometriosis can also cause significant fertility issues.

Although it affects a very large number of women, many shadows still linger around this disease, which is estimated to have an average diagnosis time of seven years. This saliva test could therefore significantly speed up the diagnosis and support for women who suffer from it.